Celecoxib and heterotopic bone formation after total hip arthroplasty

Carlos J Lavernia1, Juan S Contreras2, Jesus M Villa2

  • 1Orthopaedic Institute at Mercy Hospital, Miami, Florida.

Insights

Celecoxib effectively prevents heterotopic ossification after total hip replacement. This short-term pain management option is safe and does not affect anticoagulation.

Area of Science:

  • Orthopedic Surgery
  • Pharmacology

Background:

  • Heterotopic ossification (HO) is a common complication following total hip replacement (THR).
  • Preventing HO can improve patient outcomes and reduce revision rates.

Purpose of the Study:

  • To evaluate the efficacy of celecoxib in preventing HO after primary THR.
  • To assess the safety and impact on anticoagulation of celecoxib in this patient population.

Main Methods:

  • A prospective study of 170 consecutive primary THR patients.
  • Patients received either celecoxib (200mg twice daily for 28 days) or no celecoxib post-surgery.
  • HO incidence and severity (Brooker classification) were assessed at 3, 6, and 12 months.

Main Results:

  • HO was significantly less common in the celecoxib group at all follow-up points (P < 0.01).
  • Fewer celecoxib recipients developed moderate to severe HO (Brooker classes II/III) at 1 year.
  • No celecoxib patients had severe HO (Brooker class IV), compared to 2% in the control group. No treatment discontinuations or aseptic loosening revisions occurred.

Conclusions:

  • A short course of celecoxib aids in preventing HO after primary THR.
  • Celecoxib is a safe and effective option for HO prevention post-THR.
  • This treatment does not interfere with anticoagulation therapy.

Related Concept Videos

Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...